Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7265 p292
6 September 2003

This article
Reprint
Photocopy


News summary

Related websites
European Respiratory Journal (more)


Severe asthma may be different form of disease to mild or moderate asthma

Severe asthma may not simply be an increase in asthma symptoms, but may be a different form of the disease altogether, according to new research published in the European Respiratory Journal (2003;22:470).

A cross-sectional observational study of 321 patients has identified certain features of severe asthma that are distinct from those described for moderate or mild forms of the disease.

Patients with more severe asthma are less responsive to standard asthma therapy, and have been shown to experience greater morbidity and a lower quality of life than asthmatics whose disease is adequately controlled by therapy. This subgroup of patients has been identified as being 15 times more likely to use emergency medical care than patients with mild or moderate asthma, and 20 times more likely to require hospital admission.

Researchers from ENFUMOSA, the European Network For Understanding Mechanisms Of Severe Asthma, studied 158 patients with mild to moderate asthma, whose asthma was controlled by low doses of inhaled corticosteroids, and 163 patients with severe asthma, who had experienced at least one asthma exacerbation requiring oral steroid treatment in the past year, despite treatment with high doses of corticosteroids.

They found that females were 2.8 times more common in the severe-asthma group than males, supporting a hypothesis that severe asthma may be a sex-related disease. Evidence of structural changes in the peripheral airways or alveolar walls, sub-optimal sensitivity to glucocorticosteroids, neutrophilia and ongoing mediator release were also found to be specific to the severe-asthma group of patients. The researchers also found that severe asthma was associated with an increased body mass index, and that exposure to aspirin was a potential risk factor for severe asthma.

The authors say that severe asthma shares features with chronic obstructive pulmonary disease, and investigation into these features is needed to test the hypothesis that severe asthma is in fact a different disease to mild/moderate asthma.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal